Radius Health presents the analysis of Phase 3 Trial ACTIVE and data from preclinical studies for the injection of TYMLOS® (abaloparatide) at the ENDO 2019 annual meeting

-The post-hoc analysis suggests that abaloparatide may be useful in the treatment of women with postmenopausal osteoporosis and concomitant osteoarthritis, at high risk of fracture- – Preclinical studies provide explanations…